# Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes

> **NCT01304849** · NA · COMPLETED · sponsor: **Cancer Institute WIA** · enrollment: 50 (actual)

## Conditions studied

- Hodgkin's Lymphoma

## Interventions

- **DRUG:** Escalated BEACOPP

## Key facts

- **NCT ID:** NCT01304849
- **Lead sponsor:** Cancer Institute WIA
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01304849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01304849, "Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01304849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*